Form 4: Intuitive Surgical Executive Chair Executes Options, Sells Shares Under Pre-Arranged Plan

Intuitive Surgical's Executive Chair, Gary S. Guthart, executed stock options, sold common stock, and donated shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Gary S. Guthart, Executive Chair of the Board and Director of Intuitive Surgical Inc. (ISRG), engaged in multiple transactions on July 28, 2025.
• Acquired 7,893 shares of common stock by exercising non-qualified stock options at an exercise price of $59.4622 per share.
• Sold 7,893 shares of common stock at a weighted average price of $498.6388, with prices ranging from $494.33 to $500.00.
• Sold 1,400 shares from a Trust FBO Daughter at a weighted average price of $495.2329, with prices ranging from $493.85 to $496.31.
• Sold 1,400 shares from a Trust FBO Son at a weighted average price of $495.2405, with prices ranging from $493.85 to $496.31.
• Donated 10,500 shares to a Donor Advised Fund (DAF) at a price of $0.0.
• All transactions were conducted in accordance with a Rule 10b5-1 trading plan set to expire on April 28, 2026.
• Following these transactions, direct beneficial ownership is 13,187 shares.
• Indirect beneficial ownership includes 18,520 shares held by Trust FBO Daughter, 18,520 shares held by Trust FBO Son, and 1,204,863 shares held by Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there are significant sales, they are part of a pre-arranged 10b5-1 plan, which reduces the negative implication of insider selling. The donation of shares is a positive philanthropic act. The exercise of options at a low price relative to the sale price indicates a profitable transaction for the executive.

Positives

• Transactions were conducted under a Rule 10b5-1 trading plan, indicating pre-scheduled, non-discretionary actions.
• The donation of 10,500 shares to a Donor Advised Fund demonstrates philanthropic activity.

Negatives

• Significant sales of common stock by a key executive, totaling 10,693 shares (7,893 direct + 1,400 from Trust FBO Daughter + 1,400 from Trust FBO Son), could be perceived as a reduction in direct exposure to the company's stock.

Future Outlook

The Rule 10b5-1 trading plan, under which these transactions occurred, is set to expire on April 28, 2026, indicating potential for further pre-scheduled transactions until that date.

Industry Context

Insider transactions, particularly those executed under Rule 10b5-1 plans, are common in the medical device and robotic surgery industry as executives manage their equity compensation and personal finances.

Comparison to Industry Standards

• The reported transactions are standard for executive compensation management within the medical technology sector, where stock options and equity grants are prevalent.
• Similar activities are observed among executives at comparable companies like Medtronic, Johnson & Johnson (Ethicon), and Stryker, who also utilize 10b5-1 plans for orderly stock sales and diversification.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive, even under a 10b5-1 plan, could be viewed as a slight reduction in insider alignment, though the overall beneficial ownership remains substantial. The donation of shares has no direct financial impact on other shareholders.
• Employees: No direct impact mentioned.
• Customers/Suppliers/Creditors: No direct impact mentioned.

Next Steps

• The Rule 10b5-1 trading plan will remain active until its expiration on April 28, 2026, potentially leading to further pre-scheduled transactions.

Key Dates

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Trading, Stock Option Exercise, Share Sale, Rule 10b5-1, Executive Compensation, Gary S. Guthart, Medical Devices, Robotic Surgery